Lupus Nephritis: A Major Focus at the Lupus Research Alliance Story Updated March, 2022 Developing safe and effective treatments for lupus nephritis has been an urgent and long-standing goal in the...
Catch Up on LRA News with Lupus Research Update Vol. 1, 2022 News Update February 17, 2022 It’s with great pride that I share a sampling of the many extraordinary accomplishments of last year...
Lupus Research Alliance Congratulates Dr. Robert Califf on FDA Commissioner Appointment News Update February 17, 2022 The Lupus Research Alliance applauds the appointment of Dr. Robert Califf as the Commissioner of the U.S....
Encouraging Results with Obinutuzumab for Lupus Nephritis News Update February 13, 2022 The LRA is pleased to share a recently published paper reporting that the drug, obinutuzumab, showed positive...
LRA-Funded Research Aims at Preventing Heart Disease in Kids With Lupus Story February 14, 2022 Being a kid isn't always easy, but growing up with lupus makes it a much harder challenge....
LRA-Funded Research Found a Connection Between the Epstein-Barr Virus Infection and MS as an Autoimmune Disease News Update February 4, 2022 A potential new cause of the autoimmune disease multiple sclerosis (MS) was discovered by researchers partly funded...
Baricitinib Development as a Lupus Treatment Discontinued News Update January 28, 2022 The Lupus Research Alliance is disappointed that the Phase 3 development program of OLUMIANT® (baricitinib) as a...
LRA-Funded Research Uncovers a Novel Pathway for Lupus Nephritis News Update January 28, 2022 The investigators from The Accelerated Medicines Partnership® Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP® RA/SLE) Program, in...
Lupus Research Alliance Launches Two Major Initiatives to Increase Participation of Underrepresented Minorities in Lupus Clinical Trials and Research Press Release NEW YORK, NY. January 27 — The Lupus Research Alliance (LRA) and clinical affiliate Lupus Therapeutics (LT) announced two major initiatives improving representation...
Shingles Vaccine Recommended for Immunocompromised People News Update January 21, 2022 January, 2022 As of January, 2022, the U.S. Centers for Disease Control and Prevention (CDC) recommends the use of the...
Lupus Research Alliance Announces 11 Exceptional Recipients of the 2021 Lupus Innovation Award Press Release NEW YORK, NY, December 14, 2021. The Lupus Research Alliance proudly announced today recipients from the U.S. and around...
FDA Authorizes Evusheld Emergency Use to Prevent COVID-19 in Immunocompromised Patients News Update December 9, 2021 December 9, 2021 People with lupus can be immunocompromised because of the disease itself or medications that suppress the immune...